Jobs / United States / Glaxosmithkline LLC
Director, Real World Data Strategy and External Partnerships Lead
Glaxosmithkline LLC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles4 certified filings for “Associate Director – Genomic Technologies” (Molecular and Cellular Biologists) in PA: $134k–$138k, median $136k. Most were filed at wage level IV (50%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage, UK. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029. Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. The Director, Real World Data Strategy and External Partnerships Lead will be accountable for the strategic execution of external data partnerships to impact R&D and CPO activities, delivering insights, models and evidence and ensuring maximum scientific value demonstration from use of RWD as a key input into decision making, pipeline progress and portfolio growth. As the external data landscapes evolves globally, increasing competitive advantage is obtained by thoughtful data partnerships that align with GSK’s translational, development and commercialisation goals. Reporting to the Executive Director and Head, RWD Strategy and Partnerships, and aligned to one of our key business areas the role demands a leader who is forward thinking and can incubate potential external data partnerships by working with clinical, medical and RWE leaders to determine scientific value and impact on development programs. Alongside this, the role must work and influence stakeholders in implementation functions including our data platforms (Onyx and DDF), legal and procurement and our evolving AI enabled engineering functions to ensure partnerships deliver value quickly, are designed at source to be useful for research and analytics teams and can ensure compliant use and integration with systems, tools and models. This is a critical role in shaping and delivering the external data strategy for one of our key business areas and requires cross functional leadership, external credibility and proactive partnership development mindsets. In addition, the role will steward the investment governance process for prospective data investments and manage the portfolio of RWD and external cohorts aligned to the pipeline strategy. Lead RWD Strategy • Define and deliver Real World Data partnerships with strategic purpose at their heart. Connect and bring together leaders at the asset and therapy area level to ensure portfolio strategy continually aligns with data acquisition – refine as our pipeline evolves and be agile to respond to emerging data needs to inform future pipeline strategy • Review data strategy at regular intervals, providing feedback on governed partnerships, whilst preparing new investments for technical approval jointly with relevant senior leaders. • Develop deep relationships with senior leaders across Research Units and within Development Sciences and Medical Affairs providing frequent strategic updates; single point accountable for articulating and updating the therapy area RWD partnership strategy. • Maintain a clear inventory of data assets that drive evidence generation and in-silico modelling plans • Provide thought leadership on data quality and suitability for activities including Real World Evidence